Virios Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$5,296,015 over the previous period. Total operating expenses were $5,446,919.

Profit Margin

Virios Therapeutics, Inc. (NASDAQ:VIRI): Profit margin
2018 0 -2.11M
2019 0 -2.76M
2020 0 -10.34M
2021 0 -15.96M
2022 0 -12.18M
2023 0 -5.29M

VIRI Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
000000
Gross profit
000000
Operating exp.
Research and development
1.72M8.06M10.79M194.01K836.17K854.10K
Selling and marketing
3.71M00000
Total operating expenses
5.44M12.31M15.64M10.00M2.17M1.96M
Operating income
-5.44M-12.31M-15.64M-10.00M-2.17M-1.96M
Other income (expenses), net
150.90K67.47K-319.32K-341.00K-295.12K6
Income before tax
-5.29M-12.24M-15.96M-10.34M-2.47M-2.11M
Income tax expense
-5.44K-67.47K-15.64K-10.00K295.12K152.10K
Net income
-5.29M-12.18M-15.96M-10.34M-2.76M-2.11M
Earnings per share
Basic EPS
-0.28-1.1-1.92-1.25-0.33-0.44
Diluted EPS
-0.28-1.1-1.92-1.25-0.33-0.44
Data sourceData sourceData sourceData source